dual glp-1/gip agonist Free Comparison Chart: GLP-1 and GIP/GLP-1 Receptor Agonists for Type 2 Diabetes π Link in bio #FOAMed #Type2Diabetes #GLP1 The Emerging Role of Dual
Description
however, losing weight (and maintaining weight loss) through diet and exercise alone is challenging

doi: 10.1016/j.cell.2019.10.031 5 BeekenR

In a trial in which patients with obesity were treated with or without liraglutide 1.2 mg after diet-induced body weight loss of 12%, smaller decreases in free leptin and higher levels of PYY 3-36 were observed with liraglutide vs

In a study published in May, researchers used a large patient dataset to compare the NAION rate within 1 year of adults with Type 2 diabetes starting GLP-1 treatment (like Ozempic) versus those starting dipeptidyl peptidase 4 inhibitors

This early combination therapy with drugs targeting different actions provided better blood glucose control, decreased treatment failure, and extended the time to initiating insulin therapy [100]
